Literature DB >> 19190893

Immediate postconditioning during reperfusion attenuates intestinal injury.

Ke-Xuan Liu1, Yun-Sheng Li, Wen-Qi Huang, Shu-Qing Chen, Zhong-Xin Wang, Jia-Xin Liu, Zhengyuan Xia.   

Abstract

OBJECTIVE: To test the hypothesis that immediate but not delayed ischemic postconditioning (IPo) during reperfusion attenuates intestinal injury, and that ischemic preconditioning (IPC) and IPo may confer synergy in intestinal protection. DESIGN AND
SETTING: Prospective laboratory animal study with concurrent control.
SUBJECTS: Adult Sprague-Dawley rats.
INTERVENTIONS: Intestinal ischemia/reperfusion (II/R) injury in rats was produced by clamping superior mesenteric artery for 60 min followed by 60 min reperfusion; IPC was elicited by 10 min ischemia and 10 min reperfusion before index ischemia; IPo was performed by three cycles of 30 s reperfusion and 30 s ischemia initiated either immediately at the onset of reperfusion (IPo) or after reperfusion for 3 min (delayed-IPo). Combination of IPC and IPo was performed by combining both protocols.
MEASUREMENTS AND MAIN RESULTS: Intestinal ischemia/reperfusion resulted in significant intestinal injury evidenced as significant increase in Chiu's scores and wet-to-dry intestine weight ratio accompanied with increases in plasma levels of tumor necrosis factor-alpha and interleukin-6, as well as increases in the intestinal tissue lipid peroxidation product malonediadehyde and myeloperoxidase activity as compared to control animals (all P < 0.05). All these changes were significantly attenuated either by IPC or IPo or their combination (P < 0.05), and not by delayed-IPo (P > 0.05). IPC and IPo showed synergistic protection compared with either protocol alone.
CONCLUSION: Ischemic postconditioning reduces intestinal injury, in part, by inhibiting oxidative injury, neutrophils filtration and proinflammatory response. The early period of reperfusion is critical to intestinal protection by IPo, and intestinal protection with IPo can be enhanced by IPC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19190893     DOI: 10.1007/s00134-009-1428-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

1.  Neutrophils are primary source of O2 radicals during reperfusion after prolonged myocardial ischemia.

Authors:  C Duilio; G Ambrosio; P Kuppusamy; A DiPaula; L C Becker; J L Zweier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-06       Impact factor: 4.733

2.  Intestinal ischemic preconditioning protects the intestine and reduces bacterial translocation.

Authors:  Selim Aksöyek; Ismail Cinel; Dinçer Avlan; Leyla Cinel; Candan Oztürk; Polat Gürbüz; Ali Nayci; Uğur Oral
Journal:  Shock       Date:  2002-11       Impact factor: 3.454

3.  Endogenous endotoxemia of intestinal origin during cardiopulmonary bypass. Role of type of flow and protective effect of selective digestive decontamination.

Authors:  A E Martinez-Pellús; P Merino; M Bru; J Canovas; G Seller; J Sapiña; T Fuentes; J Moro
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

4.  Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats.

Authors:  C A Sims; S Wattanasirichaigoon; M J Menconi; A M Ajami; M P Fink
Journal:  Crit Care Med       Date:  2001-08       Impact factor: 7.598

5.  Glycogen synthase kinase-3beta inhibition attenuates the development of ischaemia/reperfusion injury of the gut.

Authors:  Salvatore Cuzzocrea; Emanuela Mazzon; Emanuela Esposito; Carmelo Muià; Maha Abdelrahman; Rosanna Di Paola; Concetta Crisafulli; Placido Bramanti; Christoph Thiemermann
Journal:  Intensive Care Med       Date:  2007-03-24       Impact factor: 17.440

6.  Propofol attenuates intestinal mucosa injury induced by intestinal ischemia-reperfusion in the rat.

Authors:  Ke-Xuan Liu; Timo Rinne; Wei He; Fang Wang; Zhengyuan Xia
Journal:  Can J Anaesth       Date:  2007-05       Impact factor: 5.063

7.  Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways.

Authors:  Xi-Ming Yang; J Bradley Proctor; Lin Cui; Thomas Krieg; James M Downey; Michael V Cohen
Journal:  J Am Coll Cardiol       Date:  2004-09-01       Impact factor: 24.094

8.  The novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin, prevents local and remote organ injury following intestinal ischemia/reperfusion in rats.

Authors:  Tomomi Suzuki; Kenichiro Yamashita; Wataru Jomen; Shinya Ueki; Takeshi Aoyagi; Moto Fukai; Hiroyuki Furukawa; Kazuo Umezawa; Michitaka Ozaki; Satoru Todo
Journal:  J Surg Res       Date:  2008-02-29       Impact factor: 2.192

9.  Propofol pretreatment reduces ceramide production and attenuates intestinal mucosal apoptosis induced by intestinal ischemia/reperfusion in rats.

Authors:  Ke-Xuan Liu; Shu-Qing Chen; Wen-Qi Huang; Yun-Sheng Li; Michael G Irwin; Zhengyuan Xia
Journal:  Anesth Analg       Date:  2008-12       Impact factor: 5.108

10.  Attenuation of reperfusion injury by renal ischemic postconditioning: the role of NO.

Authors:  Xiuheng Liu; Hui Chen; Bingyan Zhan; Bianzhi Xing; Jiangqiao Zhou; Hengcheng Zhu; Zhiyuan Chen
Journal:  Biochem Biophys Res Commun       Date:  2007-05-29       Impact factor: 3.575

View more
  26 in total

1.  The Chiu/Park scale for grading intestinal ischemia-reperfusion: if it ain't broke don't fix it!

Authors:  Mihai Oltean; Michael Olausson
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

Review 2.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

3.  Serum from patients undergoing remote ischemic preconditioning protects cultured human intestinal cells from hypoxia-induced damage: involvement of matrixmetalloproteinase-2 and -9.

Authors:  Karina Zitta; Patrick Meybohm; Berthold Bein; Christin Heinrich; Jochen Renner; Jochen Cremer; Markus Steinfath; Jens Scholz; Martin Albrecht
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

4.  Protective effect of the traditional Chinese medicine xuesaitong on intestinal ischemia-reperfusion injury in rats.

Authors:  Xuan Xu; Dengxiao Li; Hong Gao; Yuejin Gao; Long Zhang; Yuling Du; Jian Wu; Pengfei Gao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  Decreased PD-1/PD-L1 Expression Is Associated with the Reduction in Mucosal Immunoglobulin A in Mice with Intestinal Ischemia Reperfusion.

Authors:  Xu-Yu Zhang; Zi-Meng Liu; Hu-Fei Zhang; Yun-Sheng Li; Shi-Hong Wen; Jian-Tong Shen; Ke-Xuan Liu
Journal:  Dig Dis Sci       Date:  2015-05-06       Impact factor: 3.199

6.  Ischemic post-conditioning to counteract intestinal ischemia/reperfusion injury.

Authors:  Yan-Fang Guan; Timothy A Pritts; Marshall H Montrose
Journal:  World J Gastrointest Pathophysiol       Date:  2010-10-15

7.  Roles of MAPKAPK-2 and HSP27 in the reduction of renal ischemia-reperfusion injury by ischemic postconditioning in rats.

Authors:  Anzhou Xia; Yong Li; Na Li; Zhi Xue; Jieyun Xia; Tiantian Wei; Jing Cao
Journal:  Int Urol Nephrol       Date:  2014-06-14       Impact factor: 2.370

8.  Per- and post-remote ischemic conditioning attenuates ischemic brain injury via inhibition of the TLR4/MyD88 signaling pathway in aged rats.

Authors:  Jinglei Lv; Wenjing Yan; Jie Zhou; Haitao Pei; Renliang Zhao
Journal:  Exp Brain Res       Date:  2021-06-29       Impact factor: 1.972

9.  Intestinal injury can be reduced by intra-arterial postischemic perfusion with hypertonic saline.

Authors:  Oleg Kornyushin; Michael Galagudza; Anna Kotslova; Gelfia Nutfullina; Nina Shved; Alexey Nevorotin; Valeriy Sedov; Timur Vlasov
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

10.  Year in review in Intensive Care Medicine 2009: II. Neurology, cardiovascular, experimental, pharmacology and sedation, communication and teaching.

Authors:  Massimo Antonelli; Elie Azoulay; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; Daniel De Backer; François Lemaire; Herwig Gerlach; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Jerôme Pugin; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2010-01-28       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.